parenteral administration of sericystatin a , an intracellular leukocyte inhibitor of the proinsulin-splitting enzyme cathepsin b , prolongs the mean survival time of mice with insulin-dependent myeloid leukemia .
C0033362
proinsulin
C0021641
insulin